Anthera Pharmaceuticals (ANTH)

Add to Watchlists Create an Alert
2.54 +0.02  +0.79% NASDAQ Aug 29, 8:00PM BATS Real time Currency in USD
View Full Chart
ANTH Price Chart
View All Events

ANTH Events

Date Type Description
07/28/2014 Earnings Anthera Pharmaceuticals, Inc. Q2 2014 Earning Result
07/14/2014 Misc Anthera Pharmaceuticals Announces Acquisition of Sollpura® (Liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company
05/13/2014 Earnings Anthera Pharmaceuticals Inc Q1 2014 Earnings Results
03/12/2014 Earnings Anthera Pharmaceuticals, Inc. Q4 2013 Earning Result
10/29/2013 Earnings Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
View All Performance Charts

ANTH Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Anthera Pharmaceuticals is down 22.66% over the last year vs S&P 500 Total Return up 24.86%, Eli Lilly up 27.96%, and AstraZeneca up 57.51%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ANTH

Did Anthera Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ANTH Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Company Website: http://www.anthera.com
  • IR Website: http://investor.anthera.com/releases.cfm
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2013
  • Last Fiscal Year End: December 31, 2012
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Anthera Pharmaceuticals, Inc., is a biopharmaceutical company focused on developing and commercializing therapeutics to treat serious diseases associated with inflammation and autoimmune diseases.

ANTH Excel Add-In Codes

  • Name: =YCI("ANTH","name")
  • Description: =YCI("ANTH","description")
  • Sector: =YCI("ANTH","sector")
  • Industry: =YCI("ANTH","industry")
  • Est. Current Fiscal Year End: =YCI("ANTH","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.